FITLIFE BRANDS, INC. Cost of Revenue
FITLIFE BRANDS, INC. (FTLF) reported Cost of Revenue of $3.76 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2021-11-12
- FITLIFE BRANDS, INC. cost of revenue for the quarter ending 2021-09-30 was $3.76M, a 7.41% decline year-over-year.
- FITLIFE BRANDS, INC. cost of revenue for the quarter ending 2021-06-30 was $4.58M, a 222.31% increase year-over-year.
- FITLIFE BRANDS, INC. cost of revenue for the quarter ending 2021-03-31 was $3.08M, a 9.75% decline year-over-year.
- FITLIFE BRANDS, INC. cost of revenue for the quarter ending 2020-12-31 was $3.45M, a 51.96% increase year-over-year.
- FITLIFE BRANDS, INC. cost of revenue for fiscal 2020 was $12.35M, a 7.99% increase from fiscal 2019.
- FITLIFE BRANDS, INC. cost of revenue for fiscal 2019 was $11.44M, a 10.69% increase from fiscal 2018.
- FITLIFE BRANDS, INC. cost of revenue for fiscal 2018 was $10.33M, a 18.70% decline from fiscal 2017.
- FITLIFE BRANDS, INC. cost of revenue for fiscal 2017 was $12.71M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2021-09-30 | $3.76M 10-Q · filed 2021-11-12 | $8.34M derived: sum of 2 quarters · filed 2021-11-12 | $11.42M 10-Q · filed 2021-11-12 | $14.88M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $4.58M 10-Q · filed 2021-08-16 | $7.66M 10-Q · filed 2021-08-16 | $11.12M derived: sum of 3 quarters · filed 2021-08-16 | $15.18M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | $3.08M 10-Q · filed 2021-05-14 | $6.54M derived: sum of 2 quarters · filed 2021-05-14 | $10.60M derived: sum of 3 quarters · filed 2021-11-12 | $12.02M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $7.51M derived: sum of 2 quarters · filed 2021-11-12 | $8.94M derived: sum of 3 quarters · filed 2021-11-12 | $12.35M 10-K · filed 2021-03-26 |
| 2020-09-30 | $4.06M 10-Q · filed 2021-11-12 | $5.48M derived: sum of 2 quarters · filed 2021-11-12 | $8.90M 10-Q · filed 2021-11-12 | $11.17M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $1.42M 10-Q · filed 2021-08-16 | $4.83M 10-Q · filed 2021-08-16 | $7.11M derived: sum of 3 quarters · filed 2021-08-16 | $10.17M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $3.41M 10-Q · filed 2021-05-14 | $5.69M derived: sum of 2 quarters · filed 2021-05-14 | $8.75M derived: sum of 3 quarters · filed 2021-05-14 | $11.51M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $5.34M derived: sum of 2 quarters · filed 2021-03-26 | $8.10M derived: sum of 3 quarters · filed 2021-03-26 | $11.44M 10-K · filed 2021-03-26 |
| 2019-09-30 | $3.06M 10-Q · filed 2020-11-12 | $5.83M derived: sum of 2 quarters · filed 2020-11-12 | $9.16M 10-Q · filed 2020-11-12 | $11.39M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $2.76M 10-Q · filed 2020-08-13 | $6.10M 10-Q · filed 2020-08-13 | $8.33M derived: sum of 3 quarters · filed 2020-08-13 | $11.16M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $3.34M 10-Q · filed 2020-05-15 | $5.57M derived: sum of 2 quarters · filed 2020-05-15 | $8.40M derived: sum of 3 quarters · filed 2020-05-15 | $10.97M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $5.06M derived: sum of 2 quarters · filed 2020-03-30 | $7.63M derived: sum of 3 quarters · filed 2020-03-30 | $10.33M 10-K · filed 2020-03-30 |
| 2018-09-30 | $2.83M 10-Q · filed 2019-11-12 | $5.40M derived: sum of 2 quarters · filed 2019-11-12 | $8.10M 10-Q · filed 2019-11-12 | $11.09M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $2.57M 10-Q · filed 2019-08-09 | $5.27M 10-Q · filed 2019-08-09 | $8.26M derived: sum of 3 quarters · filed 2019-08-09 | $10.81M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $2.70M 10-Q · filed 2019-05-15 | $5.69M derived: sum of 2 quarters · filed 2019-05-15 | $8.24M derived: sum of 3 quarters · filed 2019-05-15 | $11.74M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $5.54M derived: sum of 2 quarters · filed 2019-03-22 | $9.04M derived: sum of 3 quarters · filed 2019-03-22 | $12.71M 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.55M 10-Q · filed 2018-11-14 | $6.05M derived: sum of 2 quarters · filed 2018-11-14 | $9.72M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $3.50M 10-Q · filed 2018-08-14 | $7.17M 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |